Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters










Publication year range
1.
Chemosphere ; 250: 126151, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32092563

ABSTRACT

The use of chlordecone (CLD), a chlorinated polycyclic pesticide used in the French West Indies banana fields between 1972 and 1993, resulted in a long-term pollution of agricultural areas. It has been observed that this persistent organic pollutant (POP) can transfer from contaminated soils to food chain. Indeed, CLD is considered almost fully absorbed after involuntary ingestion of contaminated soil by outdoor reared animals. The aim of this study was to model toxicokinetics (TKs) of CLD in growing pigs using both non-compartmental and nonlinear mixed-effects approaches (NLME). In this study, CLD dissolved in cremophor was intravenously administrated to 7 Creole growing pigs and 7 Large White growing pigs (1 mg kg-1 body weight). Blood samples were collected from time t = 0 to time t = 84 days. CLD concentrations in serum were measured by GCMS/MS. Data obtained were modeled using Monolix (2019R). Results demonstrated that a bicompartmental model best described CLD kinetics in serum. The influence of covariates (breed, initial weight and average daily gain) was simultaneously evaluated and showed that average daily gain is the main covariate explaining inter-individual TKs parameters variability. Body clearance was of 76.7 mL kg-1 d-1 and steady-state volume of distribution was of 6 L kg-1. This modeling approach constitutes the first application of NLME to study CLD TKs in farm animals and will be further used for rearing management practices in contaminated areas.


Subject(s)
Chlordecone/toxicity , Insecticides/toxicity , Animals , Chlordecone/analysis , Eating , Environmental Pollutants , Insecticides/analysis , Kinetics , Models, Chemical , Musa , Soil Pollutants/analysis , Swine , Toxicokinetics , West Indies
4.
J Vet Pharmacol Ther ; 36(5): 420-4, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23713785

ABSTRACT

In both human and veterinary medicine, it has been shown that flooding the market with different generics and/or 'me-too' branded drugs has increased overall antibiotic consumption correlating with the emergence and spread of bacterial resistance to antibiotics. Another possible undesirable consequence of the promotion of generics is the promotion of an economic incentive that encourages the use of old drug products with very poor oral bioavailability, marketed with historical dosage regimens and extensively excreted in the environment. What veterinary medicine rather needs is new innovative and 'ecofriendly' antibiotics to actually enforce a more prudent use of antibiotics. For a pharmaceutical company, generics are inexpensive to manufacture and on a short-term basis, the generic market is very appealing. However, on a long-term basis, this marketing orientation provides a disincentive to the development of new and innovative products that will be required to meet the therapeutic needs of the veterinary community while being consistent with public health concerns. Indeed, for veterinary medicine, the key issue surrounding antibiotics is public health. It is the opinion of the authors that veterinary antibiotics and/or veterinary drug formulations should be innovative in terms of selectivity (no or minimal impact on the commensal gut flora), biodegradable (with minimal environmental disruption), and more expensive, with a strictly regulated market rather than unselective, cheap, and freely available drugs.


Subject(s)
Anti-Bacterial Agents/adverse effects , Drug Resistance, Bacterial/drug effects , Drugs, Generic/adverse effects , Anti-Bacterial Agents/supply & distribution , Anti-Bacterial Agents/therapeutic use , Drug Discovery , Drug Industry , Drugs, Generic/supply & distribution , Drugs, Generic/therapeutic use , Humans , Male , Marketing , Veterinary Medicine
5.
J Vet Pharmacol Ther ; 35 Suppl 1: 39-43, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22413790

ABSTRACT

Antiparasitic drugs, and especially macrocyclic lactones (MLs), are often formulated as pour-on products because of their ease of administration, convenience, and reduction of stress in treated animals. However, because of self- and allo-grooming, much of a drug administered transdermally may be systemically absorbed via the oral route, creating highly variable pharmacokinetic and pharmacodynamic response in treated (and untreated) animals. Testing bioequivalence (BE) of pour-on drugs in cattle under laboratory conditions (with restricted licking) ignores a major factor of drug disposition of these drugs and thus fails to predict therapeutic equivalence in the target population under clinical conditions of use. Therefore, the interanimal and intra-animal variability associated with licking behavior should be considered as a biological fact, rather than a noise that needs to be reduced or eliminated. As a result, it is recommended that the BE testing for pour-on products in cattle be conducted by evaluating both the mean and distribution of bioavailability parameters between the reference and test products when animals are not prevented from allo- and self-licking.


Subject(s)
Antiparasitic Agents/administration & dosage , Antiparasitic Agents/pharmacokinetics , Behavior, Animal , Administration, Topical , Animals , Biological Availability , Cattle , Female , Male , Social Behavior , Therapeutic Equivalency
6.
Ecotoxicol Environ Saf ; 76(2): 187-92, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22047769

ABSTRACT

The genotoxicity of quinolone and fluroquinolones was assessed using the micronucleus (MN) test on Vicia faba roots by direct contact exposure to a solid matrix. Plants were exposed to quinolones (nalidixic acid) and fluoroquinolones (ciprofloxacin and enrofloxacin) alone or mixed with artificially contaminated soils. Four different concentrations of each of these antibiotics were tested (0.01, 0.1, 1 and 10 mg/Kg) for nalidixic acid and (0.005, 0.05, 0.5 and 5 mg/Kg) for ciprofloxacin and enrofloxacin. These antibiotics were also used in mixture. Exposure of Vicia faba plants to each antibiotic at the highest two concentrations showed significant MN induction. The lowest two concentrations had no significant genotoxic effect. The mixture of the three compounds induced a significant MN induction whatever the mixture tested, from 0.02 to 20 mg/Kg. The results indicated that a similar genotoxic effect was obtained with the mixture at 0.2 mg/Kg in comparison with each molecule alone at 5-10 mg/Kg. Data revealed a clear synergism of these molecules on Vicia faba genotoxicity.


Subject(s)
Fluoroquinolones/toxicity , Micronucleus Tests/methods , Mutagens/toxicity , Quinolones/toxicity , Soil Pollutants/toxicity , Vicia faba/drug effects , Anti-Bacterial Agents/toxicity , DNA Damage , Enrofloxacin , Plant Roots/drug effects , Plant Roots/genetics , Soil/chemistry , Vicia faba/genetics
7.
Appl Environ Microbiol ; 75(10): 2999-3006, 2009 May.
Article in English | MEDLINE | ID: mdl-19270132

ABSTRACT

The aim of this study was to examine the dynamics of the development of resistance in fecal Escherichia coli populations during treatment with ampicillin for 7 days in pigs. Before treatment, only 6% of the isolates were ampicillin resistant, whereas more than 90% of the isolates were resistant after days 4 and 7 of treatment. Ampicillin-resistant E. coli isolates were mainly multiresistant, and 53% of the isolates from the treated pigs had one phenotype that included resistance to six antibiotics (ampicillin, chloramphenicol, sulfonamides, tetracycline, trimethoprim, and streptomycin) at day 7. Determination of the frequency of the four phylogenetic groups showed that there was a shift in the E. coli population in ampicillin-treated pigs; before treatment 75% of the isolates belonged to phylogroup B1, whereas at day 7 85% of the isolates belonged to phylogroup A. Pulsed-field gel electrophoresis (PFGE) typing revealed that ampicillin treatment selected ampicillin-resistant isolates with genotypes which were present before treatment. Comparison of antimicrobial phenotypes and PFGE genotypes showed that resistance traits were disseminated by vertical transmission through defined strains. One PFGE genotype, associated with the six-antibiotic-resistant phenotype and including a specific combination of resistance determinants, was predominant among the ampicillin-resistant strains before treatment and during treatment. These data indicate that ampicillin administration selected various ampicillin-resistant isolates that were present in the digestive tract before any treatment and that E. coli isolates belonging to one specific PFGE genotype encoding resistance to six antibiotics became the predominant strains as soon as ampicillin was present in the digestive tract.


Subject(s)
Ampicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Drug Resistance, Multiple, Bacterial , Escherichia coli/classification , Escherichia coli/drug effects , Feces/microbiology , Swine/microbiology , Ampicillin/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Cluster Analysis , DNA Fingerprinting , Electrophoresis, Gel, Pulsed-Field , Escherichia coli/isolation & purification , Genotype , Microbial Sensitivity Tests , Selection, Genetic , Time Factors
9.
J Vet Pharmacol Ther ; 31(5): 437-45, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19000263

ABSTRACT

The first aim of the study was to investigate the pharmacokinetics of eight anticoagulant rodenticides (brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone, flocoumafen and warfarin) in plasma and liver of the mouse after single oral administration. Eight groups of mice dosed orally with a different anticoagulant rodenticide in a dose equal to one-half the lethal dose 50 (LD(50)), were killed at various times up to 21 days after administration. The eight anticoagulant rodenticides were assayed in plasma and liver by an LC-ESI-MS/MS method. Depending on the compound, the limit of quantification was set at 1 or 5 ng/mL in plasma. In liver, the limit of quantification was set at 250 ng/g for coumatetralyl and warfarin and at 100 ng/g for the other compounds. The elimination half-lives in plasma for first-generation rodenticides were shorter than those for second-generation rodenticides. Coumatetralyl, a first-generation product, had a plasma elimination half-life of 0.52 days. Brodifacoum, a second-generation product, showed a plasma elimination half-life of 91.7 days. The elimination half-lives in liver varied from 15.8 days for coumatetralyl to 307.4 days for brodifacoum. The second aim of the study was to illustrate the applicability of the developed method in a clinical case of a dog suspected of rodenticide poisoning.


Subject(s)
Anticoagulants/pharmacokinetics , Liver/metabolism , Rodenticides/pharmacokinetics , Administration, Oral , Animals , Anticoagulants/blood , Area Under Curve , Female , Half-Life , Lethal Dose 50 , Male , Mice , Rodenticides/blood , Time Factors , Tissue Distribution
10.
J Vet Pharmacol Ther ; 30(5): 375-80, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17803727

ABSTRACT

Moxidectin is a long-acting anthelmintic drug for which little is known about its kinetic behaviour in dogs and its oral absolute bioavailability has never been reported. We studied the pharmacokinetics of moxidectin in dogs, with a special emphasis on oral bioavailability and the influence of lipid co-administration, by using a semi-simultaneous method of administration. Ten Beagle dogs were dosed orally and then intravenously (i.v.) with 0.2 mg/kg moxidectin. The oral application was conducted with or without corn oil co-administration. Moxidectin concentration-time profiles in plasma were analysed using a compartmental modelling approach, designed to fit the oral and i.v. kinetic disposition curves simultaneously. In contrast to what happens in other species, our study indicates that the bioavailability of orally given moxidectin in dogs is nearly total (90.2 +/- 7.4%), and is not enhanced by lipid co-administration. The clearance, the volume of distribution, the mean residence time and the terminal half-life were similar to what was already described for other species. Finally our trial suggests that the body condition (degree of obesity) is likely to be a major determinant of moxidectin kinetics in dogs because of its modulation of the volume of distribution that indirectly controls the terminal half-life of the drug.


Subject(s)
Anthelmintics/pharmacokinetics , Dogs/metabolism , Administration, Oral , Animals , Anthelmintics/administration & dosage , Anthelmintics/blood , Biological Availability , Chemistry, Pharmaceutical , Corn Oil/administration & dosage , Female , Infusions, Intravenous , Macrolides/administration & dosage , Macrolides/blood , Macrolides/pharmacokinetics , Male
11.
Appl Environ Microbiol ; 73(15): 4785-90, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17557857

ABSTRACT

The aim of this study was to assess the impact of three ampicillin dosage regimens on ampicillin resistance among Enterobacteriaceae recovered from swine feces by use of phenotypic and genotypic approaches. Phenotypically, ampicillin resistance was determined from the percentage of resistant Enterobacteriaceae and MICs of Escherichia coli isolates. The pool of ampicillin resistance genes was also monitored by quantification of bla(TEM) genes, which code for the most frequently produced beta-lactamases in gram-negative bacteria, using a newly developed real-time PCR assay. Ampicillin was administered intramuscularly and orally to fed or fasted pigs for 7 days at 20 mg/kg of body weight. The average percentage of resistant Enterobacteriaceae before treatment was between 2.5% and 12%, and bla(TEM) gene quantities were below 10(7) copies/g of feces. By days 4 and 7, the percentage of resistant Enterobacteriaceae exceeded 50% in all treated groups, with some highly resistant strains (MIC of >256 microg/ml). In the control group, bla(TEM) gene quantities fluctuated between 10(4) and 10(6) copies/g of feces, whereas they fluctuated between 10(6) to 10(8) and 10(7) to 10(9) copies/g of feces for the intramuscular and oral routes, respectively. Whereas phenotypic evaluations did not discriminate among the three ampicillin dosage regimens, bla(TEM) gene quantification was able to differentiate between the effects of two routes of ampicillin administration. Our results suggest that fecal bla(TEM) gene quantification provides a sensitive tool to evaluate the impact of ampicillin administration on the selection of ampicillin resistance in the digestive microflora and its dissemination in the environment.


Subject(s)
Ampicillin Resistance/genetics , Ampicillin/administration & dosage , Enterobacteriaceae/drug effects , Feces/chemistry , Polymerase Chain Reaction/methods , Swine/microbiology , beta-Lactamases/genetics , Ampicillin/pharmacology , Animals , Dose-Response Relationship, Drug , Enterobacteriaceae/enzymology , Enterobacteriaceae/genetics , Escherichia coli/drug effects , Escherichia coli/enzymology , Escherichia coli/genetics , Feces/microbiology , Microbial Sensitivity Tests , Phenotype
12.
Chemosphere ; 67(2): 276-84, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17156816

ABSTRACT

The effects of water deficit stress and plant water potential (psi) on monoterpene and sesquiterpene leaf emissions from Rosmarinus officinalis, Pinus halepensis, Cistus albidus and Quercus coccifera were studied over 11 days of water withholding (from t(1) to t(11)), after substrates had achieved their field capacity (control pots: t(0)). Volatile compounds were sampled from the same twig per plant all throughout the study, using a dynamic bag enclosure system. Volatiles, collected in Tenax TA, were studied by means of GC-FID and GC-MS. Monoterpene emissions of water stressed plants (t(1)-t(11)) were either similar to those of control seedlings (R. officinalis and Q. coccifera) or higher (P. halepensis and C. albidus). By contrast, sesquiterpene emissions were strongly reduced or inhibited after four days of water withholding, particularly for R. officinalis, thus altering terpene emission composition. Despite the positive effect of water stress on leaf monoterpene emissions of P. halepensis and C. albidus, the significant correlation between these emissions and psi showed a slow decrease of these emissions over long term water deficit periods. This contrasted with the rapid decline of sesquiterpene emissions of R. officinalis according to lower values of psi. These results provide an overall picture of the different responses of monoterpene and sesquiterpene emissions to progressive water loss. They also reveal the utility of using psi for estimating some emission rates of some species according to drought conditions.


Subject(s)
Cistus/physiology , Pinus/physiology , Quercus/physiology , Rosmarinus/physiology , Sesquiterpenes/metabolism , Terpenes/metabolism , Trees/physiology , Water
13.
J Vet Pharmacol Ther ; 29(5): 337-44, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16958777

ABSTRACT

Enrofloxacin and marbofloxacin are two veterinary fluoroquinolones used to treat severe bacterial infections in horses. A repeated measures study has been designed to compare their pharmacokinetic parameters, to investigate their bioavailability and to estimate their absorbed fraction and first-pass effect by using plasma, urinary and metabolite data collected from five healthy mares. Clearance and V(d(ss)) were greater for enrofloxacin (mean +/- SD = 6.34 +/- 1.5 mL/min/kg and 2.32 +/- 0.32 L/kg, respectively) than for marbofloxacin (4.62 +/- 0.67 mL/min/kg and 1.6 +/- 0.25 L/kg, respectively). Variance of the AUC(0-inf) of marbofloxacin was lower than that for enrofloxacin, with, respectively, a CV = 15% and 26% intravenously and a CV = 31% and 55% after oral administration. Mean oral bioavailability was not significantly different between marbofloxacin (59%) and enrofloxacin (55%). The mean percentage of the dose eliminated unchanged in urine was significantly higher for marbofloxacin (39.7%) than that for enrofloxacin (3.4%). Absorbed fraction and first-pass effect were only determinable for enrofloxacin, whereas the percentage of the dose absorbed in the portal circulation was estimated to be 78% and the fraction not extracted during the first pass through the liver was 65%. Consequently, the moderate observed bioavailability of enrofloxacin appears to be mainly caused by hepatic first-pass effect.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Enzyme Inhibitors/pharmacokinetics , Fluoroquinolones/pharmacokinetics , Quinolones/pharmacokinetics , Administration, Oral , Animals , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/metabolism , Area Under Curve , Biological Availability , Ciprofloxacin/metabolism , Ciprofloxacin/pharmacokinetics , Enrofloxacin , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/metabolism , Female , Fluoroquinolones/administration & dosage , Fluoroquinolones/metabolism , Half-Life , Horses , Injections, Intravenous , Quinolones/administration & dosage , Quinolones/metabolism
14.
Vet Clin Pathol ; 34(3): 237-42, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16134071

ABSTRACT

BACKGROUND: Heparin treatment has been recommended for dogs in hypercoagulable states such as disseminated intravascular coagulation, however, potential benefits have to be balanced against the bleeding risk if overdosage occurs. A better understanding of the pharmacology of heparin and tests to monitor heparin therapy in dogs may help prevent therapeutic hazards. OBJECTIVES: The purpose of this study was to evaluate the effects of 200 U/kg of sodium unfractionated heparin (UFH) on coagulation times in dogs after intravenous (IV) and subcutaneous (SC) administration and to compare these effects with plasma heparin concentrations assessed by its antifactor Xa (aXa) activity. METHODS: 200 U/kg of UFH were administered IV and SC to 5 healthy adult Beagle dogs with a washout period of at least 3 days. Activated partial thromboplastin time (APTT), prothrombin time (PT), and plasma aXa activity were determined in serial blood samples. RESULTS: After IV injection, PT remained unchanged except for a slight increase in 1 dog; APTT was not measurable (>60 seconds) for 45-90 minutes, and then decreased gradually to baseline values between 150 and 240 minutes. High plasma heparin concentrations were observed (maximal concentration = 4.64 +/-1.4 aXa U/mL) and decreased according to a slightly concave-convex pattern on a semilogarithmic curve, but returned to baseline slightly more slowly (t240-t300 minutes) than did APTT. After SC administration, APTT was moderately prolonged (by a ratio of 1.55 +/-0.28 APTT t0, range 1.35-2.01) between 1 and 4 hours after administration. Plasma aXa activity reached a maximum of 0.56 +/-0.20 aXa U/mL (range 0.42-0.9 U/mL) after 132 +/-26.8 minutes; this lasted for 102 +/-26.8 minutes. Prolongation of APTTs of 120-160% corresponded to plasma heparin concentrations of 0.3-0.7 aXa U/mL. CONCLUSIONS: As in humans, the pharmacokinetics of UFH in dogs was nonlinear. Administration of 200 U/kg of UFH SC in healthy dogs resulted in sustained plasma heparin concentrations in accordance with human recommendations for thrombosis treatment or prevention, without excessively increased bleeding risks. In these conditions, APTT can be used as a surrogate to assess plasma heparin concentrations. These findings need to be confirmed in diseased animals.


Subject(s)
Heparin/pharmacology , Heparin/pharmacokinetics , Animals , Blood Coagulation/drug effects , Blood Coagulation Tests/veterinary , Dogs , Female , Heparin/administration & dosage , Injections, Intravenous , Injections, Subcutaneous , Male , Partial Thromboplastin Time/veterinary , Reference Values
15.
J Vet Pharmacol Ther ; 27(6): 415-25, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15601437

ABSTRACT

Plasma (total, systemic...) clearance is determined by all the individual metabolizing/eliminating organ clearances and involves mainly liver and kidney clearances. Plasma clearance (a volume per time, i.e. a flow) expresses the overall ability of the body to eliminate a drug by scaling the drug elimination rate (amount per time) by the corresponding plasma concentration level. The interpretation of plasma clearance and inter-species comparisons are made easier by computing the overall body extraction ratio (from 0 to 1), which is the ratio of the body clearance divided by cardiac output. Plasma clearance is the most important pharmacokinetic parameter because it is the only one which controls the overall drug exposure (for a given bioavailability) and it is the parameter which allows computation of the dosage required to maintain an average steady-state plasma concentration.


Subject(s)
Models, Biological , Plasma/metabolism , Veterinary Drugs/pharmacokinetics , Animals , Area Under Curve , Metabolic Clearance Rate , Models, Animal , Veterinary Drugs/administration & dosage
16.
J Vet Pharmacol Ther ; 27(6): 427-39, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15601438

ABSTRACT

Terminal plasma half-life is the time required to divide the plasma concentration by two after reaching pseudo-equilibrium, and not the time required to eliminate half the administered dose. When the process of absorption is not a limiting factor, half-life is a hybrid parameter controlled by plasma clearance and extent of distribution. In contrast, when the process of absorption is a limiting factor, the terminal half-life reflects rate and extent of absorption and not the elimination process (flip-flop pharmacokinetics). The terminal half-life is especially relevant to multiple dosing regimens, because it controls the degree of drug accumulation, concentration fluctuations and the time taken to reach equilibrium.


Subject(s)
Models, Biological , Plasma/metabolism , Veterinary Drugs/pharmacokinetics , Animals , Half-Life , Models, Animal
17.
J Vet Pharmacol Ther ; 27(6): 441-53, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15601439

ABSTRACT

Volumes of distribution are proportionality constants between total amount of drug in the body and plasma concentrations. As snapshot plasma drug concentrations may be measured in different conditions (at equilibrium, under pseudo-equilibrium condition,...), several volumes of distribution have been defined. The two most relevant are the volume of distribution at equilibrium (V(ss)), and the volume of distribution during pseudo-equilibrium (V(area)). Volumes of distribution are used to compute a loading dose (V(ss)) or the residual amount of drug in the body knowing plasma concentrations (V(area)). Volume of distribution may be interpreted in terms of drug distribution having recourse to physiological models involving drug binding to plasma and tissues. Volumes of distribution should be determined early in drug development programmes and those having a large volume of distribution may be selected to obtain a long terminal half-life even for drugs having a relatively high clearance.


Subject(s)
Models, Biological , Veterinary Drugs/pharmacokinetics , Animals , Models, Animal , Plasma Volume , Tissue Distribution , Veterinary Drugs/administration & dosage
18.
J Vet Pharmacol Ther ; 27(6): 455-66, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15601440

ABSTRACT

Bioavailability is a key pharmacokinetic parameter which expresses the proportion of a drug administered by any nonvascular route that gains access to the systemic circulation. Presented in this review are the different approaches to measurement of bioavailability (absolute and relative), including the case in which intravenous administration is impossible. The rate of drug absorption is also discussed with special emphasis on the possible difficulties encountered using C(max) and T(max) or curve fitting to evaluate the rate of drug absorption.


Subject(s)
Models, Biological , Veterinary Drugs/pharmacokinetics , Animals , Area Under Curve , Biological Availability , Models, Animal , Veterinary Drugs/administration & dosage
19.
J Vet Pharmacol Ther ; 27(5): 283-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15500564

ABSTRACT

Population pharmacokinetic of marbofloxacin was investigated on 21 healthy and 16 diseased horses to assess interindividual variability of drug exposure. Demographic, physiologic and disease covariables were tested using mixed effects models. As a preliminary analysis, this study has demonstrated that none of the tested covariables were significant in regression models for compartmental volumes or clearance of distribution, but the clinical status of the horse (healthy/diseased) was a significant covariable (P < 0.01) for systemic clearance. Clearance had a lower mean and a higher variance for diseased horses than healthy horses, with respectively a mean of 0.209 and 0.284 L/h/kg and a coefficient of variation of 52 and 15%. Consequently, variability of AUC was greater in diseased horses. Considering an AUC/MIC ratio below 60 h as a prediction of poor efficacy, a dosage regimen of 2 mg/kg intravenous was deemed to be inadequate for 19% of diseased horses if the MIC of the bacteria was 0.1 microg/mL. However 93% of diseased horses could achieve a ratio above 125 h, predicting a very good efficacy, for the MIC(90) of Enterobacteriacae (0.027 microg/mL).


Subject(s)
Anti-Infective Agents/pharmacokinetics , Enzyme Inhibitors/pharmacokinetics , Fluoroquinolones/pharmacokinetics , Horse Diseases/metabolism , Horses/metabolism , Quinolones/pharmacokinetics , Topoisomerase II Inhibitors , Animals , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/blood , Area Under Curve , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/blood , Female , Fluoroquinolones/administration & dosage , Fluoroquinolones/blood , Gastritis/drug therapy , Gastritis/veterinary , Horse Diseases/drug therapy , Injections, Intramuscular , Male , Mastitis/drug therapy , Mastitis/veterinary , Quinolones/administration & dosage , Quinolones/blood , Regression Analysis , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/veterinary
20.
Chemosphere ; 52(1): 239-48, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12729707

ABSTRACT

Foliar phenol concentrations (total and simple phenols) were determined in Aleppo pine (Pinus halepensis Mill.) needles collected in June 2000, from 6 sites affected by various forms of atmospheric pollutants (NO, NO(2), NO(x), O(3) and SO(2)) monitored during two months. Results show an increase in total phenol content with exposure to sulphur dioxide and a reduction with exposure to nitrogen oxide pollution. p-Coumaric acid, syringic acid and 4-hydroxybenzoic acid concentrations increase with exposure to nitrogen oxide pollution, whereas gallic acid and vanillin decrease in the presence respectively of sulphur dioxide and ozone. This in situ work confirms the major interest of using total and simple phenolic compounds of P. halepensis as biological indicators of air quality.


Subject(s)
Air Pollutants/analysis , Environmental Monitoring/methods , Phenols/analysis , Pinus/chemistry , Plant Leaves/chemistry , Air Pollutants/adverse effects , Biological Assay , Biomarkers/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...